Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Can we use gonadotropin plasma concentration as surrogate marker for BMI-related incomplete estrogen suppression in breast cancer patients receiving anastrozole?
Oberguggenberger A, Meraner V, Sztankay M, Beer B, Weigel G, Oberacher H, Kemmler G, Czech T, Holzner B, Wildt L, Sperner-Unterweger B, Daniaux M, Hubalek M. Oberguggenberger A, et al. Among authors: meraner v. BMC Cancer. 2017 Mar 28;17(1):226. doi: 10.1186/s12885-017-3208-6. BMC Cancer. 2017. PMID: 28351392 Free PMC article.
Fatigue in ovarian carcinoma patients: a neglected issue?
Holzner B, Kemmler G, Meraner V, Maislinger A, Kopp M, Bodner T, Nguyen-Van-Tam D, Zeimet AG, Fleischhacker WW, Sperner-Unterweger B. Holzner B, et al. Among authors: meraner v. Cancer. 2003 Mar 15;97(6):1564-72. doi: 10.1002/cncr.11253. Cancer. 2003. PMID: 12627522 Free article.
Is the toxicity of adjuvant aromatase inhibitor therapy underestimated? Complementary information from patient-reported outcomes (PROs).
Oberguggenberger A, Hubalek M, Sztankay M, Meraner V, Beer B, Oberacher H, Giesinger J, Kemmler G, Egle D, Gamper EM, Sperner-Unterweger B, Holzner B. Oberguggenberger A, et al. Among authors: meraner v. Breast Cancer Res Treat. 2011 Jul;128(2):553-61. doi: 10.1007/s10549-011-1378-5. Epub 2011 Feb 11. Breast Cancer Res Treat. 2011. PMID: 21311968
Adherence evaluation of endocrine treatment in breast cancer: methodological aspects.
Oberguggenberger AS, Sztankay M, Beer B, Schubert B, Meraner V, Oberacher H, Kemmler G, Giesinger J, Gamper E, Sperner-Unterweger B, Marth C, Holzner B, Hubalek M. Oberguggenberger AS, et al. Among authors: meraner v. BMC Cancer. 2012 Oct 15;12:474. doi: 10.1186/1471-2407-12-474. BMC Cancer. 2012. PMID: 23066928 Free PMC article.
22 results